Skip to main content

Table 3 Correlation analyses between MMSE and expression levels of 17A, 51A, BACE1 and BC200 in plasma of Alzheimer disease (AD) patients and control (Ctrl) groups

From: Plasma long non-coding RNA BACE1 as a novel biomarker for diagnosis of Alzheimer disease

LEL

MMSE (Ctrl)

MMSE (AD)

MMSE (AD + Control)

r2

CI (95%)

P value

r2

CI (95%)

P value

r2

CI (95%)

P value

17A

0.06

−0.06~0.53

0.12

0.01

−0.21~0.37

0.48

0.262

0.032~0.443

0.012

51A

0.07

−0.10~ − 0.54

0.10

0.02

−0.41~0.12

0.31

0.168

−0.049~0.368

0.105

BACE1

0.05

−0.10~0.51

0.16

0.002

−0.22~0.30

0.79

0.303

0.071~0.480

0.003

BC200

0.02

−0.03~0.50

0.09

0.0001

−0.30~0.30

0.95

0.184

−0.036~0.403

0.079

  1. LEL LncRNA expression level, AD Alzheimer disease, r spearman correlation coefficient, r2 coefficient of determination